Symptom research in gynecologic oncology: A review of available measurement tools

Gynecologic Oncology

Volumn 119, Issue 2, 2010, Pages 384-389

  Agarwal, Sonika ^a   Bodurka, Diane C ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Assessment; Cervical cancer; Gynecologic cancer; Ovarian cancer; Symptoms; Vulvar cancer

Indexed keywords

ABDOMINAL DISCOMFORT; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER SCREENING; CANCER THERAPY; CLINICAL ASSESSMENT TOOL; DIAGNOSTIC TEST; GYNECOLOGIC CANCER; HEALTH SURVEY; HUMAN; OUTCOME ASSESSMENT; OVARY CANCER; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; STUDY DESIGN; SYMPTOMATOLOGY; UTERINE CERVIX CANCER; VULVA CANCER; FEMALE; GENITAL NEOPLASMS, FEMALE; GYNECOLOGY; ONCOLOGY; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOLOGY;

FEMALE; GENITAL NEOPLASMS, FEMALE; GYNECOLOGY; HUMANS; MEDICAL ONCOLOGY; QUALITY OF LIFE;

EID: 77957749795     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.07.009     Document Type: Review

References (27)

1. J. Homsi, D. Walsh, K.A. Nelson, S.B. Legrand, M. Davis, and E. Khawam The impact of a palliative medicine and consultation service in medical oncology Support Care Cancer 10 4 2002 337 342
2. C.S. Cleeland, T.R. Mendoza, X.S. Wang, C. Chou, M.T. Harle, and M. Morrissey Assessing symptom distress in cancer patients: the M. D. Anderson Symptom Inventory Cancer 89 7 2000 1634 1646
3. C.S. Cleeland, and C.C. Reyes-Gibby When it is justified to treat symtoms? Measuring symptom burden Oncology (Huntington) 16 9 Suppl 10 2002 64 70
4. R.K. Portenoy, H.T. Thaler, A.B. Kornblith, J.M. Lepore, H. Friedlander-Klar, and N. Coyle Symptom prevalence, characteristics and distress in a cancer population Qual Life Res 3 3 1994 183 189
5. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999-2005 Incidence and Mortality Web-Based Report. Atlanta (GA): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Cancer Institute; 2009 [cited 2009 Oct 9]. Available from www.cdc.gov/uscs.
6. C.S. Cleeland Symptom burden: multiple symptoms and their impact as patient-reported outcomes J Natl Cancer Inst Monogr 37 2007 16 21
7. A.M. Barsevick, K. Whitmer, L.M. Nail, S.l. Beck, and W.N. Dudley Symptom cluster research: conceptual, design, measurement, and analysis issues J Pain Symptom Manage 31 2006 85 95
8. S.W. Fox, and D. Lyon Symptom clusters and quality of life in survivors of ovarian cancer Cancer Nursing 30 5 2007 354 361
9. J. Kirkova, M.P. Davis, D. Walsh, E. Tiernan, N. O'Leary, and S.B. LeGrand Cancer symptom assessment instruments: a systematic review J Clin Oncol 24 9 2006 1459 1473
10. K. Basen-Engquist, D. Bodurka-Bevers, M.A. Fitzgerald, K. Webster, D. Cella, and S. Hu Reliability and validity of the functional assessment of cancer therapy-ovarian J Clin Oncol 19 6 2001 1809 1817
11. L. Wanzel, H.Q. Huang, D. Cella, J.L. Walker, and D.K. Armstrong Validation of FACT/GOG-AD subscale for ovarian cancer-related abdominal discomfort: a gynecologic oncology group study Gynecol Oncol 11 1 2008 60 64
12. C.C. Sun, D.C. Bodurka, C.B. Weaver, R. Rasu, J.K. Wolf, and M.W. Bevers Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer Support Care Cancer 13 4 2005 219 227
13. A. Cull, S. Howat, E. Greimel, A.C. Waldenstrom, J. Arraras, and A. Kudelka Development of a European Organization for Research and Treatment of Cancer questionnaire module to assess the quality of life of ovarian cancer patients in clinical trials: a progress report Eur J Cancer 37 1 2001 47 53
14. E. Greimel, A. Bottomley, A. Cull, A.C. Waldenstrom, J. Arraras, and L. Chauvenet An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-OV28) in assessing the quality of life of patients with ovarian cancer Eur J Cancer 39 10 2003 1402 1408
15. E. Basch, D. Artz, D. Dulko, K. Scher, P. Sabbatini, and M. Hensley Patient online self-reporting of toxicity symptoms during chemotherapy J Clin Oncol 23 15 2005 3552 3561
16. W. Hamilton, T.J. Peters, C. Bankhead, and D. Sharp Risk of ovarian cancer in women with symptoms in primary care: population based case-control study BMJ 339 2009 b2998
17. B.A. Goff, L.S. Mandel, C.W. Drescher, N. Urban, S. Gough, and K.M. Schurman Development of an ovarian cancer symptom index: possibilities for earlier detection Cancer 109 2 2007 221 227
18. M.R. Anderson, B.A. Goff, K.A. Lowe, N. Scholler, L. Bergen, and C.W. Drescher Combining a symptoms index with CA 125 to improve detection of ovarian cancer Cancer 113 3 2008 484 489
19. C.R. Bankhead, C. Collins, H. Stokes-Lampard, P. Rose, S. Wilson, and A. Clements Identifying symptoms of ovarian cancer: a qualitative and quantitative study BJOG 115 2008 1008 1014
20. E.R. Greimel, K. Kuljanic Vlasic, A.C. Waldenstrom, V.M. Duric, P.T. Jensen, and S. Singer The European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Cervical Cancer Module: EORTC QLQ-CX24 Cancer 107 8 2006 1812 1822
21. H. Jayasekara, L. Rajapaksa, and E.R. Greimel The EORTC QLQ-CX24 cervical cancer-specific quality of life questionnaire: psychometric properties in a South Asian sample of cervical cancer patients Psychooncology 17 10 2008 1053 1057
22. A. Ditto, F. Martinelli, C. Borreani, S. Kusamura, F. Hanozet, and C. Brunelli Quality of life and sexual, badder, and intestinal dysfunctions after Class III nerve-sparing and Class II radical hysterectomies: a questionnaire-based study Int J Gynecol Cancer 19 5 2009 953 957
23. K.T. Ashing-Giwa, J. Kim, and J.S. Tejero Measuring quality of life among cervical cancer survivors: preliminary assessment of instrumentation validity in a cross-cultural study Qual Life Res 17 2008 147 157
24. M. Frumovitz, C.S. Sun, L.R. Schover, M.F. Munsell, A. Jhingran, and J.T. Wharton Quality of life and sexual functioning in cervical cancer survivors J Clin Oncol 23 2005 7428 7436
25. M. Jando, A. Obermair, D. Cella, L.C. Perrin, J. Nicklin, and B.G. Ward The Functional Assessment of Cancer - Vulvar: reliability and validity Gynecol Oncol 97 2 2005 568 575 (Pubitemid 40614905)
26. C.S. Cleeland, T.R. Mendoza, X.S. Wang, C. Chou, M.T. Harle, and M. Morrissey Assessing symptom distress in cancer patients: the M D Anderson Symptom Inventory Cancer 89 7 2000 1634 1646
27. Food and Drug Administration Guidelines for Industry Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims 2010 Available from: URL: http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM071975.pdf. Accessed Apr 7, 2010